453
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Risk assessment of dietary exposure to tryptamine for the Austrian population

, , , &
Pages 404-420 | Received 13 Oct 2016, Accepted 01 Dec 2016, Published online: 23 Dec 2016

References

  • Aktories K, Förstermann U, Hofmann FB, Starke K. 2013. Allgemeine und spezielle Pharmakologie und Toxikologie [General and specific pharmacology and toxicology]. 11th ed. Munich: Elsevier Health Sciences.
  • Anwar MA, Ford WR, Broadley KJ, Herbert AA. 2012. Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and beta-phenylethylamine. Br J Pharmacol. 165:2191–2202.
  • Anwar MA, Ford WR, Herbert AA, Broadley KJ. 2013. Signal transduction and modulating pathways in tryptamine-evoked vasopressor responses of the rat isolated perfused mesenteric bed. Vascul Pharmacol. 58:140–149.
  • Askar A. 1978. Serotonin and tryptamine - Origin, metabolism and function in the human organism. Aktuel Ernahrungsmed. 3:125–131.
  • Askar A, Treptow H. 1986. Biogene Amine in Lebensmitteln: Vorkommen, Bedeutung und Bestimmung [Biogenic amines in food: occurrence, relevance and determination]. Ulmer: Stuttgart.
  • Bacaloni A, Insogna S, Sancini A, Ciarrocca M, Sinibaldi F. 2013. Sensitive profiling of biogenic amines in human urine by capillary electrophoresis with field amplified sample injection. Biomed Chromatogr. 27:987–993.
  • Barker SA, McIlhenny EH, Strassman R. 2012. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010. Drug Test Anal. 4:617–635.
  • Bauer F, Paulsen P. 2000. Die Bedeutung biogener Amine in Fleisch und Fleischwaren und Maßnahmen zur Einschränkung ihrer Bildung [The importance of biogenic amines in meat and meat products and measures to limit their formation]. In: Bauer F, Pfannhauser W, editors. Flair flow Europe Workshop - Sichere Herstellung von Fleisch und Fleischwaren. Wien: Institut für Fleischhygiene der VMU Wien; p. 93–104.
  • Bauer F, Paulsen P, Hagen U, Wasserbacher R, Elmadfa I, Ralph A, Bardocz S. 2004. The intake of biogenic amines in the diet. In: Wallace HM, Hughes A, editors. COST action 922: health implications of dietary amines. Luxembourg: Office for EC publications; p. 34–41.
  • Berry MD. 2004. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem. 90:257–271.
  • Berry MD. 2007. The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev Recent Clin Trials. 2:3–19.
  • Berry MD, Shitut MR, Almousa A, Alcorn J, Tomberli B. 2013. Membrane permeability of trace amines: evidence for a regulated, activity-dependent, nonexocytotic, synaptic release. Synapse. 67:656–667.
  • Beutling DM. 1996. Biogene Amine und Mikroben [Biogenic amines and microbes]. In: Beutling DM, editor. Biogene Amine in der Ernährung. Berlin: Springer; p. 59–103.
  • Beutling DM, Bergmann HW, Schlenker GR. 1996. Allgemeines über biogene Amine [General information on biogenic amines]. In: Beutling DM, editor. Biogene Amine in der Ernährung. Berlin: Springer; p. 2–58.
  • Bonetta S, Bonetta S, Carraro E, Coïsson JD, Travaglia F, Arlorio M. 2008. Detection of biogenic amine producer bacteria in a typical Italian goat cheese. J Food Prot. 71:205–209.
  • Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, et al. 2001. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A. 98:8966–8971.
  • Bortolato M, Shih JC. 2011. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol. 100:13–42.
  • Bosin TR, Hixson EJ, Maickel RP. 1976. Pressor effects of tryptamine analogues. Br J Pharmacol. 56:25–27.
  • Bover-Cid S, Miguelez-Arrizado MJ, Vidal-Carou MC. 2001. Biogenic amine accumulation in ripened sausages affected by the addition of sodium sulphite. Meat Sci. 59:391–396.
  • Branchek TA, Blackburn TP. 2003. Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol. 3:90–97.
  • Brimblecombe RW, Downing DF, Green DM, Hunt RR. 1964. Some pharmacological effects of a series of tryptamine derivatives. Br J Pharmacol Chemother. 23:43–54.
  • Broadley KJ. 2010. The vascular effects of trace amines and amphetamines. Pharmacol Ther. 125:363–375.
  • Buňka F, Budinský P, Čechová M, Drienovský V, Pachlová V, Matoulková D, Kubán V, Buňková L. 2012. Content of biogenic amines and polyamines in beers from the Czech republic. J Inst Brew. 118:213–216.
  • Buňka F, Budinský P, Zimáková B, Merhaut M, Flasarová R, Pachlová V, Kubáň V, Buňková L. 2013. Biogenic amines occurrence in fish meat sampled from restaurants in region of Czech republic. Food Control. 31:49–52.
  • Burchett SA, Hicks TP. 2006. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol. 79:223–246.
  • Chang SF, Ayres JW, Sandine WE. 1985. Analysis of cheese for histamine, tyramine, tryptamine, histidine, tyrosine, and tryptophane. J Dairy Sci. 68:2840–2846.
  • Clineschmidt BV, Lotti VJ. 1974. Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses. Br J Pharmacol. 50:311–313.
  • Coisson JD, Cerutti C, Travaglia F, Arlorio M. 2004. Production of biogenic amines in ‘Salamini italiani alla cacciatora PDO’. Meat Sci. 67:343–349.
  • Cox B, Lee TF, Martin D. 1981. Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat. Br J Pharmacol. 72:477–482.
  • D’Andrea G, D’Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, Galloni E, De Riva V, D’Arrigo A, Colavito D, et al. 2014. Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache. Neurol Sci. 35:1941–1945.
  • Daniel D, Dos Santos VB, Vidal DT, Do Lago CL. 2015. Determination of biogenic amines in beer and wine by capillary electrophoresis-tandem mass spectrometry. J Chromatogr A. 1416:121–128.
  • Dooley DJ, Quock RM. 1976. Tryptamine and 5-hydroxytryptamine-induced hypothermia in mice. J Pharm Pharmacol. 28:775–776.
  • Eble JN. 1965. A study of the potentiation of tryptamine by monoamine oxidase inhibitors in the dog. J Pharmacol Exp Ther. 148:48–53.
  • [ECHA] European Chemicals Agency. 2014. Guidance on information requirements and chemical safety assessment. Helsinki: ECHA. Chapter R.7c, Endpoint specific guidance. Version 2.0; p. 162–236.
  • Edwards ST, Sandine WE. 1981. Symposium: microbial metabolites of importance in dairy products - Public health significance of amines in cheese. J Dairy Sci. 64:2431–2438.
  • Eerola HS, Roig Sagués AX, Hirvi TK. 1998. Biogenic amines in Finnish dry sausages. J Food Saf. 18:127–138.
  • [EFSA] European Food Safety Authority. 2011. Scientific opinion on risk based control of biogenic amine formation in fermented foods. J. 9:2393–2486.
  • Elmadfa I, Freisling H, Nowak V, Hofstädter D. 2009. Österreichischer Ernährungsbericht 2008 [Austrian Nutrition Report 2008]. Vienna: Institute of Nutritional Sciences, University of Vienna.
  • European Commission. 2009. RASFF alert no. 2009.1676: tryptamine in preserved anchovy from the United Kingdom. Brussels: EC Health and Consumers Directorate-General.
  • Ewins AJ, Laidlaw PP. 1913. The fate of indolethylamine in the organism. Biochem J. 7:18–25.
  • [FAO]/[WHO] Food and Agriculture Organization of the United Nations,World Health Organization. 2009. Principles and methods for the risk assessment of chemicals in food: environmental health criteria 240. Geneva: FAO, WHO. Chapter 6, Dietary Exposure Assessment of Chemicals in Food; p. 1–95.
  • Frecska E, Szabo A, Winkelman MJ, Luna LE, McKenna DJ. 2013. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm (Vienna). 120:1295–1303.
  • Galgano F, Suzzi G, Favati F, Caruso M, Martuscelli M, Gardini F, Salzano G. 2001. Biogenic amines during ripening in ‘Semicotto Caprino’cheese: role of enterococci. Int J Food Sci Technol. 36:153–160.
  • Gaya P, Sanchez C, Nunez M, Fernandez-Garcia E. 2005. Proteolysis during ripening of Manchego cheese made from raw or pasteurized ewes’ milk. Seasonal variation. J Dairy Res. 72:287–295.
  • Ginzel KH, Kottegoda SR. 1954. The action of 5-hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat. J Physiol (Lond). 123:277–288.
  • Goldberg M, Hanani M, Nissan S. 1986. Effects of serotonin on the internal anal sphincter: in vivo manometric study in rats. Gut. 27:49–54.
  • Gosetti F, Mazzucco E, Gennaro MC, Marengo E. 2013. Simultaneous determination of sixteen underivatized biogenic amines in human urine by HPLC-MS/MS. Anal Bioanal Chem. 405:907–916.
  • Gosetti F, Mazzucco E, Gianotti V, Polati S, Gennaro MC. 2007. High performance liquid chromatography/tandem mass spectrometry determination of biogenic amines in typical Piedmont cheeses. J Chromatogr A. 1149:151–157.
  • Green H, Sawyer JL. 1960. Correlation of tryptamine-induced convulsions in rats with brain tryptamine concentration. Proc Soc Exp Biol Med. 104:153–155.
  • Hagen P, Weiner N. 1959. Enzymic oxidation of pharmacologically active amines. Fed Proc. 18:1005–1012.
  • Hagen U, Paulsen P, Bauer F. 2005. Concentrations of biogenic amines and polyamines in fresh fish sold at retail level in Vienna. In: Morgan DML, Bauer F, White A, editors. COST action 917 - Biogenically active amines in food - Volume VII. Luxembourg: Office for Official Publications of the European Communities; p. 187–190.
  • Honecker H, Coper H, Fahndrich C, Rommelspacher H. 1980. Identification of tetrahydronorharmane (tetrahydro-beta-carboline) in human blood platelets. J Clin Chem Clin Biochem. 18:133–135.
  • Hwang D-F, Chang S-H, Shiau C-Y, Cheng -C-C. 1995. Biogenic amines in the flesh of sailfish (Istiophorus platypterus) responsible for scombroid poisoning. J Food Sci. 60:926–928.
  • Innocente N, D’Agostin P. 2002. Formation of biogenic amines in a typical semihard Italian cheese. J Food Prot. 65:1498–1501.
  • Innocente N, Marino M, Marchesini G, Biasutti M. 2009. Presence of biogenic amines in a traditional salted Italian cheese. Int J Dairy Technol. 62:154–160.
  • Inubushi T, Kamemura N, Oda M, Sakurai J, Nakaya Y, Harada N, Suenaga M, Matsunaga Y, Ishidoh K, Katunuma N. 2012. L-tryptophan suppresses rise in blood glucose and preserves insulin secretion in type-2 diabetes mellitus rats. J Nutr Sci Vitaminol (Tokyo). 58:415–422.
  • Izquierdo-Pulido M, Mariné-Font A, Vidal-Carou MC. 1994. Biogenic amines formation during malting and brewing. J Food Sci. 59:1104–1107.
  • Janssen PA, Niemegeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF. 1988. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther. 244:685–693.
  • Jones RS. 1982. Tryptamine: a neuromodulator or neurotransmitter in mammalian brain? Prog Neurobiol. 19:117–139.
  • Joosten HM. 1988a. Conditions allowing the formation of biogenic amines in cheese. 3. Factors influencing the amounts formed. Neth Milk Dairy J. 41:329–357.
  • Joosten HM. 1988b. The biogenic amine contents of Dutch cheese and their toxicological significance. Neth Milk Dairy J. 42:25–42.
  • Kalač P, Špička J, Křížek M, Pelikánová T. 2000. The effects of lactic acid bacteria inoculants on biogenic amines formation in sauerkraut. Food Chem. 70:355–359.
  • Karkkainen J, Forsstrom T, Tornaeus J, Wahala K, Kiuru P, Honkanen A, Stenman UH, Turpeinen U, Hesso A. 2005. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scand J Clin Lab Invest. 65:189–199.
  • Katikou P, Georgantelis D, Paleologos EK, Ambrosiadis I, Kontominas MG. 2006. Relation of biogenic amines’ formation with microbiological and sensory attributes in Lactobacillus-inoculated vacuum-packed rainbow trout (Oncorhynchus mykiss) fillets. J Agric Food Chem. 54:4277–4283.
  • Keszthelyi D, Troost FJ, Masclee AA. 2009. Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol Motil. 21:1239–1249.
  • Koral S, Tufan B, Ščavničar A, Kočar D, Pompe M, Köse S. 2013. Investigation of the contents of biogenic amines and some food safety parameters of various commercially salted fish products. Food Control. 32:597–606.
  • Korn A, Da Prada M, Raffesberg W, Allen S, Gasic S. 1988. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor. J Neural Transm Suppl. 26:57–71.
  • Köse S, Koral S, Tufan B, Pompe M, Scavniçar A, Koçar D. 2012. Biogenic amine contents of commercially processed traditional fish products originating from European countries and Turkey. Eur Food Res Technol. 235:669–683.
  • Kosson R, Elkner K. 2010. Effect of storage period on biogenic amine content in sauerkraut. Veg Crops Res Bull. 73:151–160.
  • Kung HF, Tsai YH, Wei CI. 2007. Histamine and other biogenic amines and histamine-forming bacteria in miso products. Food Chem. 101:351–356.
  • Ladero V, Calles-Enríquez M, Fernández M, Alvarez MA. 2010. Toxicological effects of dietary biogenic amines. Curr Nutr Food Sci. 6:145–156.
  • Laidlaw PP. 1912. The physiological action of indolethylamine. Biochem J. 6:141–150.
  • Lee H, Kim S-H, Sang C-I, Jun H, Eun J-B, An H. 2005. Histamine and other biogenic amines and bacterial isolation in retail canned anchovies. J Food Sci. 70:C145–C150.
  • Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR. 2014. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology. 81:283–291.
  • Lindemann L, Hoener MC. 2005. A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci. 26:274–281.
  • Lorenzo JM, Martínez S, Franco I, Carballo J. 2008. Biogenic amine content in relation to physico-chemical parameters and microbial counts in two kinds of Spanish traditional sausages. Arch Lebensmittelhyg. 59:70–75.
  • Marino M, Maifreni M, Moret S, Rondinini G. 2000. The capacity of Enterobacteriaceae species to produce biogenic amines in cheese. Lett Appl Microbiol. 31:169–173.
  • Martin WR, Sloan JW. 1970. Effects of infused tryptamine in man. Psychopharmacologia. 18:231–237.
  • Martin WR, Sloan JW. 1986. Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens. Pharmacol Biochem Behav. 24:393–399.
  • Matejkova K, Krizek M, Vacha F, Dadakova E. 2013. Effect of high-pressure treatment on biogenic amines formation in vacuum-packed trout flesh (Oncorhynchus mykiss). Food Chem. 137:31–36.
  • Mayer HK, Fiechter G, Fischer E. 2010. A new ultra-pressure liquid chromatography method for the determination of biogenic amines in cheese. J Chromatogr A. 1217:3251–3257.
  • Mousseau DD, Layrargues GP, Butterworth RF. 1994. Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem. 62:621–625.
  • Nauman K, Paulsen P, Vali S, Smulders FJM. 2014. Contents of biogenic amines, total aerobic counts, and prevalence of nematode larvae and Listeria monocytogenes in fish and fish products sold at retail in Vienna. Arch Lebensmittelhyg. 65:116–120.
  • Niemegeers CJ, Lenaerts FM, Artois KS, Janssen PA. 1977. Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new ‘in vivo’ approach: the ATN-test in rats. Arch Int Pharmacodyn Ther. 227:238–253.
  • Novella-Rodríguez S, Veciana-Nogués MT, Izquierdo-Pulido M, Vidal-Carou MC. 2003. Distribution of biogenic amines and polyamines in cheese. J Food Sci. 68:750–755.
  • Novella-Rodríguez S, Veciana-Nogués MT, Roig-Sagues AX, Trujillo-Mesa AJ, Vidal-Carou MC. 2002. Influence of starter and nonstarter on the formation of biogenic amine in goat cheese during ripening. J Dairy Sci. 85:2471–2478.
  • Novella-Rodríguez S, Veciana-Nogués MT, Roig-Sagues AX, Trujillo-Mesa AJ, Vidal-Carou MC. 2004. Comparison of biogenic amine profile in cheeses manufactured from fresh and stored (4 degrees C, 48 hours) raw goat’s milk. J Food Prot. 67:110–116.
  • Nut.s. 2016. Nutritional Software with BLS (Bundeslebensmittelschlüssel) version 3.02, ÖNWT (Österreichische Nährwerttabelle). Online version, data status per 25.04.2016. Vienna. dato Denkwerkzeuge. Available from: www.nutritional-software.at
  • Okuyama S, Chaki S, Yoshikawa R, Suzuki Y, Ogawa S, Imagawa Y, Kawashima N, Ikeda Y, Kumagai T, Nakazato A, et al. 1997. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045). J Pharmacol Exp Ther. 282:56–63.
  • Özogul F, Gökbulut C, Özogul Y, Özyurt G. 2006. Biogenic amine production and nucleotide ratios in gutted wild sea bass (Dicentrarchus labrax) stored in ice, wrapped in aluminium foil and wrapped in cling film at 4°C. Food Chem. 98:76–84.
  • Paley EL, Denisova G, Sokolova O, Posternak N, Wang X, Brownell AL. 2007. Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models. Neuromolecular Med. 9:55–82.
  • Paley EL, Perry G, Sokolova O. 2013. Tryptamine induces axonopathy and mitochondriopathy mimicking neurodegenerative diseases via tryptophanyl-tRNA deficiency. Curr Alzheimer Res. 10:987–1004.
  • Papavergou EJ, Savvaidis IN, Ambrosiadis IA. 2012. Levels of biogenic amines in retail market fermented meat products. Food Chem. 135:2750–2755.
  • Paulsen P, Grossgut R, Bauer F, Rauscher-Gabernig E. 2012. Estimates of maximum tolerable levels of tyramine content in foods in Austria. J Food Nutr Res. 51:52–59.
  • Paulsen P, Hagen U, Bauer F. 2005. Appendix I – table II: fish and fish products. In: Morgan DML, Bauer F, White A, editors. COST action 917 - Biogenically active amines in food - Volume VII. Luxembourg: Office for Official Publications of the European Communities; p. 281–282.
  • Quock RM, Weick BG. 1978. Tryptamine-induced drug effects insensitive to serotoninergic antagonists: evidence of specific tryptaminergic receptor stimulation? J Pharm Pharmacol. 30:280–283.
  • Rauscher-Gabernig E, Gabernig R, Brueller W, Grossgut R, Bauer F, Paulsen P. 2012. Dietary exposure assessment of putrescine and cadaverine and derivation of tolerable levels in selected foods consumed in Austria. Eur Food Res Technol. 235:209–220.
  • Rauscher-Gabernig E, Grossgut R, Bauer F, Paulsen P. 2009. Assessment of alimentary histamine exposure of consumers in Austria and development of tolerable levels in typical foods. Food Control. 20:423–429.
  • Rauscher-Gabernig E, Grossgut R, Bauer F, Paulsen P. 2010. Phenylethylamine in foods: concentrations and development of maximum tolerable levels. Wien Tierarztl Monatsschr. 97:242–252.
  • Renes E, Diezhandino I, Fernandez D, Ferrazza RE, Tornadijo ME, Fresno JM. 2014. Effect of autochthonous starter cultures on the biogenic amine content of ewe’s milk cheese throughout ripening. Food Microbiol. 44:271–277.
  • Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, et al. 2013. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry. 18:543–556.
  • Romero R, Bagur MG, Sanchez-Vinas M, Gazquez D. 2003. The influence of the brewing process on the formation of biogenic amines in beers. Anal Bioanal Chem. 376:162–167.
  • Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. 2006. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 8:1–27.
  • Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, Hartung T, Hoffmann S. 2009. ‘ToxRTool’, a new tool to assess the reliability of toxicological data. Toxicol Lett. 189:138–144.
  • Senöz B, Işikli N, Çoksöyler N. 2000. Biogenic amines in Turkish sausages (sucuks). J Food Sci. 65:764–767.
  • Shalaby AR. 1996. Significance of biogenic amines to food safety and human health. Food Res Int. 29:675–690.
  • Shukla S, Park HK, Kim JK, Kim M. 2010. Determination of biogenic amines in Korean traditional fermented soybean paste (Doenjang). Food Chem Toxicol. 48:1191–1195.
  • Shulgin AT, Shulgin A. 1997. TIHKAL: the continuation. Berkley: Erwoid Online Books, Transform Press. Chapter 53, Tryptamine; Indole, 3-(2-aminoethyl); 3-(2-aminoethyl)indole. [ cited 2015 Mar 31]. Available from: https://erowid.org/library/books_online/tihkal/tihkal53.shtml
  • Sieber R, Bilic N. 1992. Über die Bildung der biogenen Amine im Käse [About the formation of biogenic amines in cheese]. Schweiz Landw Forschung. 31:33–58.
  • Silla Santos MH. 1996. Biogenic amines: their importance in foods. Int J Food Microbiol. 29:213–231.
  • Simonova A, Pfannhauser W. 2001. The influence of storage conditions on the formation biogenic amines in meat, fish and vegetables. Ernährung/Nutrition. 25:253–259.
  • Slomkowska A, Ambroziak W. 2002. Biogenic amine profile of the most popular Polish beers. Eur Food Res Technol. 215:380–383.
  • Spano G, Russo P, Lonvaud-Funel A, Lucas P, Alexandre H, Grandvalet C, Coton E, Coton M, Barnavon L, Bach B, et al. 2010. Biogenic amines in fermented foods. Eur J Clin Nutr. 64:S95–S100.
  • Špička J, Kalač P, Bover-Cid S, Křížek M. 2002. Application of lactic acid bacteria starter cultures for decreasing the biogenic amine levels in sauerkraut. Eur Food Res Technol. 215:509–514.
  • Stadnik J, Dolatowski ZJ. 2012. Biogenic amines content during extended ageing of dry-cured pork loins inoculated with probiotics. Meat Sci. 91:374–377.
  • Stute R, Petridis K, Steinhart H, Biernoth G. 2002. Biogenic amines in fish and soy sauces. Eur Food Res Technol. 215:101–107.
  • Su TP, Hayashi T, Vaupel DB. 2009. When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal. 2:pe12.
  • Sugimoto Y, Kimura I, Yamada J, Watanabe Y, Takeuchi N, Horisaka K. 1991. The involvement of insulin in tryptamine-induced hypoglycemia in mice. Life Sci. 48:1679–1683.
  • Sullivan JP, McDonnell L, Hardiman OM, Farrell MA, Phillips JP, Tipton KF. 1986. The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues. Biochem Pharmacol. 35:3255–3260.
  • Suzzi G, Gardini F. 2003. Biogenic amines in dry fermented sausages: a review. Int J Food Microbiol. 88:41–54.
  • Tang T, Shi T, Qian K, Li P, Li J, Cao Y. 2009. Determination of biogenic amines in beer with pre-column derivatization by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 877:507–512.
  • Tedeschi DH, Tedeschi RE, Fellows EJ. 1959. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs. J Pharmacol Exp Ther. 126:223–232.
  • Ten Brink B, Damink C, Joosten HM, Huis In’t Veld JH. 1990. Occurrence and formation of biologically active amines in foods. Int J Food Microbiol. 11:73–84.
  • Tipton KF. 2002. Biogenic amines, diet and the properties of amine oxidases. In: Morgan D, Hirvi T, Dandrifosse G, Deloyer P, White A, editors. COST 917 - Biogenically active amines in food - Volume VI. Luxembourg: Office for Official Publications of the European Communities; p. 117–121.
  • Toro-Funes N, Bosch-Fuste J, Latorre-Moratalla ML, Veciana-Nogues MT, Vidal-Carou MC. 2015. Biologically active amines in fermented and non-fermented commercial soybean products from the Spanish market. Food Chem. 173:1119–1124.
  • Van der Goot AT, Nollen EA. 2013. Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends Mol Med. 19:336–344.
  • Van Oekelen D, Megens A, Meert T, Luyten WH, Leysen JE. 2002. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats. Behav Pharmacol. 13:313–318.
  • Veciana-Nogués MT, Albala-Hurtado S, Mariné-Font A, Vidal-Carou MC. 1996. Changes in biogenic amines during the manufacture and storage of semipreserved anchovies. J Food Prot. 59:1218–1222.
  • Veciana-Nogués MT, Hernández-Jover T, Mariné-Font A, Vidal-Carou MC. 1995. Liquid chromatographic method for determination of biogenic amines in fish and fish products. J AOAC Int. 78:1045–1050.
  • Veciana-Nogués MT, Mariné-Font A, Vidal-Carou MC. 1997. Changes in biogenic amines during the storage of Mediterranean anchovies immersed in oil. J Agric Food Chem. 45:1385–1389.
  • Vitale AA, Pomilio AB, Canellas CO, Vitale MG, Putz EM, Ciprian-Ollivier J. 2011. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine. J Nucl Med. 52:970–977.
  • Weiß C. 2009. Biogene Amine [Biogenic amines]. Ernährungs Umschau. 3:172–179.
  • Weissbach H, King W, Sjoerdsma A, Udenfriend S. 1959. Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. J Biol Chem. 234:81–86.
  • Williams BB, Van Benschoten AH, Cimermancic P, Donia MS, Zimmermann M, Taketani M, Ishihara A, Kashyap PC, Fraser JS, Fischbach MA. 2014. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 16:495–503.
  • Yamada J, Sugimoto Y, Horisaka K. 1987. The behavioural effects of intravenously administered tryptamine in mice. Neuropharmacology. 26:49–53.
  • Yamada J, Sugimoto Y, Kimura I, Watanabe Y, Horisaka K. 1994. Effects of tryptamine on plasma glucagon levels in mice. Neurochem Res. 19:15–18.
  • Yang J, Ding X, Qin Y, Zeng Y. 2014. Safety assessment of the biogenic amines in fermented soya beans and fermented bean curd. J Agric Food Chem. 62:7947–7954.
  • Yongsawatdigul J, Rodtong S, Raksakulthai N. 2007. Acceleration of Thai fish sauce fermentation using proteinases and bacterial starter cultures. J Food Sci. 72:M382–M390.
  • Young SN, Gauthier S. 1981. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 44:323–328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.